Biologic therapies have become a breakthrough treatment option for managing various type 2 inflammatory conditions, such as asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps. Explore our collection of articles to learn more about biologics, their benefits, and how they’re being used to treat different inflammatory diseases and conditions.
Biologic medications can significantly reduce symptoms for many people with moderate to severe asthma. They target specific parts of the immune system that cause airway inflammation, stopping asthma symptoms before they can start.
Starting a biologic medication may seem a bit overwhelming. But it can be a big help in managing your chronic…
Type 2 inflammation is an overactive immune response. It plays a major role in chronic diseases such as asthma, allergies, eczema, and more. It can lead to significant inflammation in the airways and skin.
Many people wonder if their health insurance will provide coverage for biologics. The good news is that most health insurance plans do cover biologic medications.
End of content
End of content
This website was developed by the American Partnership for Eosinophilic Disorders (APFED) and the Allergy & Asthma Network (AAN).
Founded in 2001 by parents of children living with eosinophil-associated diseases, the American Partnership for Eosinophilic Disorders (APFED) is a 501(c)(3) nonprofit organization. APFED assists and supports patients and families affected by eosinophil-associated disorders by providing education, creating awareness, supporting research, and promoting advocacy.
Connect with APFED on social media:
Allergy & Asthma Network (AAN) is the leading national organization advocating on behalf of the 50 million Americans with allergies, asthma and related conditions. Founded in 1985, the Network’s mission has remained, “to end needless death & suffering due to asthma, allergies, and related conditions through outreach, education, advocacy, and research.”
Connect with AAN on social media:
Supported by:
Contact Us | Privacy Policy | Accessibility Statement. |. Sitemap
© 2022-2025 American Partnership for Eosinophilic Disorders (APFED)
and the Allergy & Asthma Network (AAN)
All Rights Reserved